RESUMEN
El Consorcio Internacional para la Medición de Resultados en Salud (ICHOM, por sus siglas en inglés) se especializa en el desarrollo de conjuntos de medidas de resultado de tratamientos para condiciones de salud con el objetivo de mejorar la práctica clínica. ICHOM desarrolló una propuesta de medidas de resultado para depresión, ansiedad, trastorno obsesivo-compulsivo y trastorno por estrés postraumático, en población infanto-juvenil de entre 6 y 24 años que fue publicada el 2021. Un grupo de trabajo internacional de 27 personas expertas en clínica, en investigación y por experiencia vivida, alcanzó el consenso a través del método Delphi adaptado con votación anónima iterativa, apoyada por insumos de investigación. Se propone evaluar síntomas, pensamientos y conductas suicidas y funcionalidad a través de siete medidas de resultado informadas primariamente por el o la paciente. Las recomendaciones fueron validadas a través de una encuesta que involucró a 487 participantes en 45 países. Este artículo presenta sugerencias para su aplicación en Chile. Palabras claves: Depresión, ansiedad, infanto-juvenil, medidas de resultado, consenso internacional.
Abstract: The International Consortium for Health Outcomes Measurement (ICHOM) specializes in developing sets of outcome measures for health conditions with the goal of improving clinical practice. ICHOM developed a proposal for outcome measures for depression, anxiety, obsessive-compulsive disorder and post-traumatic stress disorder in children and young people aged 6 to 24 years that was published in 2021. An international working group of 27 clinical, research, and lived experience experts, reached consensus through the adapted Delphi method, and iterative anonymous voting, supported by research inputs. It is proposed to assess symptoms, suicidal thoughts, and behavior, and functioning through seven primarily patient-reported outcome measures. The recommendations were validated through a survey involving 487 participants across 45 countries. This article presents suggestions for their application in Chile.Keywords: depression, anxiety, child and youth, outcome measures, international consensus
RESUMEN
Context: The International Consensus Group for Hematology Review (ICGHR) are essentially review criteria designed to reduce the number of manual smear reviews following analysis in automated hematology analyzers (AHAs). Although AHAs are an indispensable part of the present-day clinical laboratory, manual smear reviews still play an integral role in identifying morphological abnormalities and to confirm the results of the analyzers. Aims: The aim of this study is to evaluate the efficacy of the ICGHR criteria and our laboratory criteria using the Sysmex XN-1000 for manual peripheral smear review (MSR). Study Design: A prospective cross-sectional comparative study between the two sets of criteria for MSR was performed. Material and Methods: A total of 860 whole blood samples sent over a period of 19 months for complete blood count testing to our laboratory were collected using systematic random sampling. Truth tables were prepared for each set of criteria. Tests of proportion were used to compare performance specifications between both sets of criteria. Results: Using ICGHR criteria, sensitivity was 81.58%, specificity was 84.61%, 83.38% positive predictive value, and 82.92% negative predictive value. The microscopic smear review rate was 47.56% and efficiency was 83.14%. Using our laboratory criteria, sensitivity was 98.80%, specificity was 41.40%, positive predictive value of 61.46%, and negative predictive value of 97.34%. The microscopic smear review rate was 78.14% and efficiency 69.30%. Conclusions: There was a significant reduction in the microscopic smear review rates using the ICGHR criteria compared to our laboratory criteria. The ICGHR criteria can thus be adapted to daily laboratory practice provided they are first optimized and locally validated before use.
RESUMEN
Pancreatic cysts have many histological subtypes. With development of imaging techniques such as computed tomography and magnetic resonance imaging, detection rate of pancreatic cysts has been increasing. And standardized diagnosis and treatment of pancreatic cysts remains a clinical challenge. Due to insufficient understanding of imaging features and tumor markers of pancreatic cysts, a reasonable procedure of diagnosis and treatment has not been published so far. Several guidelines for the diagnosis and treatment of pancreatic cysts with high impact have been published, including international consensus guidelines, European experts consensus statement and American Gastroenterological Association guidelines. This review focused on the diagnosis and treatment strategies and suggestions proposed by the above guidelines, and application of endoscopic ultrasonography, so as to provid references for treatment of pancreatic cysts.
RESUMEN
Autoimmune pancreatitis should be differentiated from pancreatobiliary cancers because they often have similar clinical features and images. Accurate and practical diagnostic algorithm for AIP is important to avoid unnecessary surgery and delayed treatment. International Consensus Diagnostic Criteria for AIP suggested that diagnostic algorithms and the practical patterns considerably vary worldwide. Patients with clinically suspected AIP can be categorized into patients with typical features of AIP and patients with indeterminate features based on CT findings. Serology and other organ involvement can be used as collateral evidence of AIP. If a patient presents with diffuse pancreatic enlargement but is lack of collateral evidence, pancreatogram could be useful. If a patient has obstructive jaundice, biliary drainage and endobiliary biopsy are recommended. Duodenal papillary biopsy for IgG4 immunostain can be used during ERCP. In case of atypical imaging findings, EUS-guided FNA/biopsy is recommended to exclude pancreatic cancer and to obtain the suggestive findings of AIP. If type 2 is clinically suspected, EUS-guided core biopsy is required for the definite diagnosis. Short-term steroid trial can be performed to confirm the diagnosis of AIP when pancreatobiliary cancer workup shows negative results. However, clinical practice in diagnosing AIP varies depending on the local expertise, facilities, cost, prevalence of AIP and its subtypes.